# Zeal Capital

Zeal Capital is a Private Equity based in Washington Dc, China.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Washington Dc, China
- **Region:** Asia
- **Address:** Shanghai, China
- **Founded:** 2020
- **Assets under management:** Undisclosed
- **Website:** https://www.zealcapitalpartners.com
- **LinkedIn:** https://www.linkedin.com/company/zeal-capital-partners

## Regulatory record

- **CRD number:** 314354
- **SEC file number:** 802-122335
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/314354

## About

Zeal Capital Partners partners with early-stage founders building enduring companies across financial technology, healthcare, and the future of learning and work. The firm invests in companies intentionally closing gaps in wealth, health, and skills and partners long-term to build category-leading businesses. It aims to invest in early-stage companies that are turbocharging economic mobility, with health equity as a natural extension of its existing categories of financial inclusion and the future of work and learning.

## People

- Nasir Qadree — Founder and Managing Partner
- Emily Zhen — Principal
- Stefanie Thomas-Martin — Partner
- Graham McLaughlin — Health Equity Executive-in-Residence

## Questions

### What investment stages does Zeal Capital typically target?

Public records indicate Zeal Capital deploys capital across early-stage seed rounds, startup financings, and expansion-stage growth equity — a full lifecycle approach from company formation through later venture rounds, all within China's technology sector.

### Where does Zeal Capital primarily invest geographically?

The firm's investment activity is concentrated in mainland China, with its headquarters in Shanghai functioning as the primary origination hub. There is no public indication of outbound cross-border investment mandates.

### Does Zeal Capital participate in fund commitments or only direct deals?

Available evidence points to a direct-investment model targeting equity stakes in portfolio companies, rather than a fund-of-funds approach. No public records indicate the firm allocates capital to external venture funds.

## Related profiles

- [ZCJS Capital](https://altss.com/profile/zcjs-capital)
- [Zehou Capital](https://altss.com/profile/zehou-capital)

---

Last updated: 2026-08-11T15:08:42.881Z

Canonical page: https://altss.com/profile/zeal-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology